JP2013542218A5 - - Google Patents

Download PDF

Info

Publication number
JP2013542218A5
JP2013542218A5 JP2013535549A JP2013535549A JP2013542218A5 JP 2013542218 A5 JP2013542218 A5 JP 2013542218A5 JP 2013535549 A JP2013535549 A JP 2013535549A JP 2013535549 A JP2013535549 A JP 2013535549A JP 2013542218 A5 JP2013542218 A5 JP 2013542218A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound
following formula
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013535549A
Other languages
English (en)
Japanese (ja)
Other versions
JP5647356B2 (ja
JP2013542218A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/054643 external-priority patent/WO2012056372A1/en
Publication of JP2013542218A publication Critical patent/JP2013542218A/ja
Publication of JP2013542218A5 publication Critical patent/JP2013542218A5/ja
Application granted granted Critical
Publication of JP5647356B2 publication Critical patent/JP5647356B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013535549A 2010-10-29 2011-10-18 N1/N2−ラクタムアセチル−CoAカルボキシラーゼ阻害剤 Expired - Fee Related JP5647356B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40812710P 2010-10-29 2010-10-29
US61/408,127 2010-10-29
US201161531744P 2011-09-07 2011-09-07
US61/531,744 2011-09-07
PCT/IB2011/054643 WO2012056372A1 (en) 2010-10-29 2011-10-18 N1/N2-LACTAM ACETYL-CoA CARBOXYLASE INHIBITORS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014225021A Division JP2015057416A (ja) 2010-10-29 2014-11-05 N1/N2−ラクタムアセチル−CoAカルボキシラーゼ阻害剤

Publications (3)

Publication Number Publication Date
JP2013542218A JP2013542218A (ja) 2013-11-21
JP2013542218A5 true JP2013542218A5 (https=) 2014-01-30
JP5647356B2 JP5647356B2 (ja) 2014-12-24

Family

ID=44993633

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013535549A Expired - Fee Related JP5647356B2 (ja) 2010-10-29 2011-10-18 N1/N2−ラクタムアセチル−CoAカルボキシラーゼ阻害剤
JP2014225021A Withdrawn JP2015057416A (ja) 2010-10-29 2014-11-05 N1/N2−ラクタムアセチル−CoAカルボキシラーゼ阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014225021A Withdrawn JP2015057416A (ja) 2010-10-29 2014-11-05 N1/N2−ラクタムアセチル−CoAカルボキシラーゼ阻害剤

Country Status (26)

Country Link
US (3) US8859773B2 (https=)
EP (2) EP2952514A1 (https=)
JP (2) JP5647356B2 (https=)
KR (2) KR101529404B1 (https=)
CN (2) CN104774205A (https=)
AR (1) AR083578A1 (https=)
AU (1) AU2011322117B2 (https=)
BR (1) BR112013010310A2 (https=)
CA (1) CA2815169C (https=)
CY (1) CY1116405T1 (https=)
DK (1) DK2632925T3 (https=)
ES (1) ES2546465T3 (https=)
HK (1) HK1209733A1 (https=)
HU (1) HUE025078T2 (https=)
IL (1) IL225779A0 (https=)
MX (1) MX2013004733A (https=)
NZ (1) NZ609527A (https=)
PL (1) PL2632925T3 (https=)
PT (1) PT2632925E (https=)
RU (1) RU2540337C2 (https=)
SG (1) SG189883A1 (https=)
SI (1) SI2632925T1 (https=)
TW (3) TWI441823B (https=)
UY (1) UY33694A (https=)
WO (1) WO2012056372A1 (https=)
ZA (1) ZA201303882B (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2546465T3 (es) * 2010-10-29 2015-09-23 Pfizer Inc Inhibidores de N1/N2-lactama acetil-CoA carboxilasa
PL2953942T3 (pl) 2013-02-06 2018-03-30 Bayer Cropscience Aktiengesellschaft Podstawione halogenem pochodne pirazolu jako środki do zwalczania szkodników
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN103214327A (zh) * 2013-03-22 2013-07-24 郑州泰基鸿诺药物科技有限公司 一种芳香环或芳杂环三氟甲基酮化合物及其制备方法
CN104230922B (zh) 2013-06-19 2016-12-28 中国科学院上海药物研究所 一类五元杂环并吡啶类化合物及其制备方法和用途
US20160220557A1 (en) 2013-09-12 2016-08-04 Pfizer Inc. Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris
MX2016008653A (es) 2014-01-03 2016-09-26 Bayer Animal Health Gmbh Nuevas pirazolil-heteroarilamidas como agentes plaguicidas.
CN104844509A (zh) * 2014-02-14 2015-08-19 河南工业大学 一种条件温和无金属参与的胺基喹啉衍生物的制备方法
KR101731624B1 (ko) * 2014-07-01 2017-05-04 광주과학기술원 세포 리프로그래밍 유도용 조성물
CN106749002A (zh) * 2015-02-12 2017-05-31 佛山市赛维斯医药科技有限公司 一种含硝基喹啉结构的葡萄糖激酶活化剂及其用途
BR112017019266B1 (pt) 2015-03-10 2022-05-10 Bayer Animal Health Gmbh Compostos derivados de pirazolila e composição farmacêutica compreendendo o referido composto
IL243707A0 (en) 2016-01-20 2016-05-01 Galmed Res And Dev Ltd Treatment to regulate the microbiota in the intestine
US11197870B2 (en) 2016-11-10 2021-12-14 Galmed Research And Development Ltd Treatment for hepatic fibrosis
WO2018170203A1 (en) 2017-03-16 2018-09-20 Celgene Car Llc Mk2 inhibitors, synthesis thereof, and intermediates thereto
WO2018170200A1 (en) 2017-03-16 2018-09-20 Celgene Car Llc Heteroaryl compounds useful as mk2 inhibitors
AU2018233367B2 (en) 2017-03-16 2021-08-12 Jiangsu Hengrui Medicine Co., Ltd. Heteroaryl[4,3-c]pyrimidine-5-amine derivative, preparation method therefor, and medical uses thereof
EP3601259B1 (en) 2017-03-30 2022-02-23 F. Hoffmann-La Roche AG Isoquinolines as inhibitors of hpk1
CN111406056B (zh) 2017-11-21 2023-02-28 辉瑞公司 选择性acc抑制剂的结晶2-氨基-2-(羟甲基)丙烷-1,3-二醇盐
TW202019905A (zh) 2018-07-24 2020-06-01 瑞士商赫孚孟拉羅股份公司 異喹啉化合物及其用途
TW202024053A (zh) 2018-10-02 2020-07-01 美商建南德克公司 異喹啉化合物及其用途
US11612606B2 (en) 2018-10-03 2023-03-28 Genentech, Inc. 8-aminoisoquinoline compounds and uses thereof
CN109824669A (zh) * 2018-12-21 2019-05-31 西南大学 哌啶螺环酒石酸类化合物制备及应用
EP4149917B1 (en) * 2020-05-12 2025-07-30 Merck Sharp & Dohme LLC Factor xi activation inhibitors
EP4154880A4 (en) * 2020-05-21 2024-06-05 Shionogi & Co., Ltd Pharmaceutical for treating fatty liver diseases
CN116670142A (zh) 2021-02-01 2023-08-29 细胞基因公司 Mk2抑制剂、其合成和其中间体
TW202317104A (zh) * 2021-06-25 2023-05-01 美商賽迪拉治療股份有限公司 Tead抑制劑及其用途
MA71611A (fr) * 2022-07-29 2025-05-30 Pfizer Inc. Nouveaux inhibiteurs de l'acc
CN121241054A (zh) * 2023-04-14 2025-12-30 北京双鹤润创科技有限公司 氮杂环羰基稠环衍生物及其用途
CN121909191A (zh) * 2023-08-16 2026-04-21 智擎生技制药股份有限公司 Mta协同性的prmt5抑制剂
TW202602453A (zh) * 2024-03-14 2026-01-16 智擎生技製藥股份有限公司 Mta協同性的prmt5抑制劑

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002100A (en) 1932-06-27 1935-05-21 Smith Sheffield Shock absorber
JPS4925673B1 (https=) * 1970-05-22 1974-07-02
ES2287971T3 (es) 1997-08-11 2007-12-16 Pfizer Products Inc. Dispersiones farmaceuticas solidas con biodisponibilidad incrementada.
CA2439152C (en) 2001-02-28 2008-06-17 Merck & Co., Inc. Acylated piperidine derivatives as melanocortin-4 receptor agonists
JP2005504059A (ja) 2001-08-24 2005-02-10 ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー 疾患を処置するための置換アリール7−アザ[2.2.1]ビシクロヘプタン
WO2003072578A1 (en) 2002-02-20 2003-09-04 Pharmacia & Upjohn Company Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
CN1642599A (zh) 2002-02-27 2005-07-20 辉瑞产品公司 Acc抑制剂
US7105526B2 (en) 2002-06-28 2006-09-12 Banyu Pharmaceuticals Co., Ltd. Benzimidazole derivatives
WO2004092179A1 (ja) 2003-04-14 2004-10-28 Nippon Soda Co. Ltd. スピロ誘導体、製造法および抗酸化薬
JP2005119987A (ja) 2003-10-15 2005-05-12 Ajinomoto Co Inc アシルスルホンアミド誘導体
PL1753748T3 (pl) 2004-05-12 2010-01-29 Pfizer Prod Inc Pochodne proliny i ich zastosowanie jako inhibitorów peptydazy dipeptylowej IV
WO2005113069A2 (en) 2004-05-14 2005-12-01 Research Development Foundation Use of circumin and analogues as inhibitors of acc2
AP2006003768A0 (en) 2004-05-25 2006-10-31 Pfizer Prod Inc TetraazabenzoÄeÜazulene derivatives and analogs tehereof
PA8660701A1 (es) 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
WO2007011809A1 (en) 2005-07-19 2007-01-25 Merck & Co., Inc. Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors
CA2617042A1 (en) 2005-07-29 2007-02-01 Takeda Pharmaceutical Company Limited Spiro-cyclic compound
JP2009515971A (ja) 2005-11-18 2009-04-16 メルク エンド カムパニー インコーポレーテッド スピロヒダントインアリールcgrp受容体アンタゴニスト
JP2009526868A (ja) 2006-02-15 2009-07-23 アボット・ラボラトリーズ 新規なアセチル−CoAカルボキシラーゼ(ACC)阻害薬およびこれらの糖尿病、肥満および代謝症候群における使用
EP2010520B1 (en) 2006-04-20 2012-09-12 Pfizer Products Inc. Heterobicyclic amides for the prevention and treatment of glucokinase-mediated diseases
BRPI0721053A2 (pt) 2006-11-29 2014-07-29 Pfizer Prod Inc INIBIDORES DE ESPIROCETONA ACETIL-CoA CARBOXILASE
PE20081559A1 (es) 2007-01-12 2008-11-20 Merck & Co Inc DERIVADOS DE ESPIROCROMANONA SUSTITUIDOS COMO INHIBIDORES DE ACETIL CoA CARBOXILASA
JPWO2008102749A1 (ja) * 2007-02-20 2010-05-27 武田薬品工業株式会社 複素環化合物
AU2008237660B2 (en) 2007-04-12 2011-12-22 Pfizer Inc. 3-amido-pyrrolo [3, 4-C] pyrazole-5 (1H, 4H, 6H) carbaldehyde derivatives as inhibitors of protein kinase C
US20090036425A1 (en) 2007-08-02 2009-02-05 Pfizer Inc Substituted bicyclolactam compounds
US7981904B2 (en) 2008-03-20 2011-07-19 Takeda Pharmaceutical Company Limited Acetyl CoA carboxylase inhibitors
JP5435592B2 (ja) 2008-05-28 2014-03-05 ファイザー・インク ピラゾロスピロケトンアセチルCoAカルボキシラーゼ阻害剤
WO2009144555A1 (en) 2008-05-28 2009-12-03 Pfizer Inc. Pyrazolospiroketone acetyl-coa carboxylase inhibitors
WO2010002010A1 (en) 2008-07-04 2010-01-07 Banyu Pharmaceutical Co.,Ltd. Novel spirochromanone carboxylic acids
AU2009271634A1 (en) * 2008-07-14 2010-01-21 Cropsolution, Inc. Modulators of acetyl-coenzyme a carboxylase and methods of use thereof
JP2011529483A (ja) 2008-07-29 2011-12-08 ファイザー・インク フッ素化ヘテロアリール
AU2009286380B2 (en) 2008-08-28 2011-09-15 Pfizer Inc. Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
TW201038580A (en) 2009-02-02 2010-11-01 Pfizer 4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl derivatives
CA2754685A1 (en) 2009-03-11 2010-09-16 Pfizer Inc. Substituted indazole amides
EP2604604A1 (en) 2009-03-11 2013-06-19 Pfizer Inc Benzofuranyl derivatives used as glucokinase inhibitors
WO2010106457A2 (en) 2009-03-20 2010-09-23 Pfizer Inc. 3-oxa-7-azabicyclo[3.3.1]nonanes
CA2759843A1 (en) 2009-05-08 2010-11-10 Pfizer Inc. Gpr 119 modulators
US20120052130A1 (en) 2009-05-08 2012-03-01 Pfizer Inc. Gpr 119 modulators
NZ596467A (en) 2009-06-05 2014-01-31 Pfizer L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
WO2011005611A1 (en) 2009-07-09 2011-01-13 Merck Sharp & Dohme Corp. Neuromedin u receptor agonists and uses thereof
EP2499140A1 (en) * 2009-11-10 2012-09-19 Pfizer Inc. N2-pyrazolospiroketone acetyl-coa carboxylase inhibitors
EP2947082A1 (en) * 2009-11-10 2015-11-25 Pfizer Inc N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS
HRP20161178T1 (hr) 2010-09-30 2016-11-04 Pfizer Inc. N1-PIRAZOLOSPIROKETONSKI INHIBITORI ACETIL-CoA-KARBOKSILAZE
ES2546465T3 (es) * 2010-10-29 2015-09-23 Pfizer Inc Inhibidores de N1/N2-lactama acetil-CoA carboxilasa

Similar Documents

Publication Publication Date Title
JP2013542218A5 (https=)
RU2013116924A (ru) N1/n2-лактамные ингибиторы ацетил-коа-карбоксилаз
JP2013507434A5 (https=)
JP2013537203A5 (https=)
JP2015512931A5 (https=)
JP2016501250A5 (https=)
MD20140084A2 (en) New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same
JP2012140436A5 (ja) 物質
JP2012092103A5 (https=)
JP2012522729A5 (https=)
JP2013510120A5 (https=)
JP2013544860A5 (https=)
JP2011137006A5 (https=)
JP2009263394A5 (https=)
JP2010265321A5 (https=)
JP2010503688A5 (https=)
EA201700230A1 (ru) Определенные аминопиридины, композиции на их основе и способы их применения
JP2015537020A5 (https=)
JP2016503793A5 (https=)
JP2013147496A5 (ja) 有機金属錯体
JP2013163667A5 (https=)
JP2016531126A5 (https=)
JP2014500861A5 (https=)
JP2011042653A5 (https=)
JP2013533253A5 (https=)